Marker Therapeutics (MRKR) Misses Q3 EPS by 12c
Marker Therapeutics (NASDAQ: MRKR) reported Q3 EPS of ($0.12). Revenue for the quarter came in at $1.23 million.
For earnings history and earnings-related data on Marker Therapeutics (MRKR) click here.
Marker Therapeutics (NASDAQ: MRKR) reported Q3 EPS of ($0.12). Revenue for the quarter came in at $1.23 million.
For earnings history and earnings-related data on Marker Therapeutics (MRKR) click here.